VHCP Management II as of Dec. 31, 2015
Portfolio Holdings for VHCP Management II
VHCP Management II holds 15 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Edge Therapeutics | 18.2 | $22M | 1.9M | 11.47 | |
| Regenxbio Inc equity us cm (RGNX) | 13.0 | $16M | 1.0M | 15.40 | |
| Dbv Technologies | 11.6 | $14M | 230k | 61.46 | |
| Ascendis Pharma A S (ASND) | 10.8 | $13M | 721k | 18.32 | |
| Cytomx Therapeutics (CTMX) | 9.6 | $12M | 603k | 19.31 | |
| Alcobra | 5.8 | $7.1M | 1.1M | 6.28 | |
| Coherus Biosciences (CHRS) | 4.9 | $6.0M | 259k | 22.96 | |
| Lipocine | 4.5 | $5.4M | 420k | 12.93 | |
| Akari Therapeutics | 4.4 | $5.4M | 370k | 14.50 | |
| ARCA biopharma | 4.1 | $5.0M | 1.1M | 4.65 | |
| Global Blood Therapeutics In | 3.8 | $4.6M | 142k | 32.33 | |
| Cynapsus Therapeutics | 3.3 | $4.0M | 257k | 15.44 | |
| Avalanche Biotechnologies In | 2.2 | $2.7M | 280k | 9.52 | |
| Pronai Therapeutics | 2.2 | $2.6M | 175k | 15.04 | |
| D Stemline Therapeutics | 1.6 | $2.0M | 316k | 6.31 |
